Biogen shelves ALS drug after early-stage trial failure | BioPharma Dive

Retrieved on: 2022-03-29 04:26:25

Tags for this article:

Neurological disorders

Life Sciences

Branches of biology

Spinal muscular atrophy

Therapeutic gene modulation

Antisense RNA

Motor neuron diseases

Neuromuscular Disorders

Biogen

Ionis Pharmaceuticals

Antisense therapy

Nusinersen

Click the tags to see associated articles and topics

Biogen shelves ALS drug after early-stage trial failure | BioPharma Dive. View article details on HISWAI: https://www.biopharmadive.com/news/biogen-ionis-als-drug-study-failure-genetic/621107/

Excerpt

Biogen will stop work on an experimental ALS drug it's developing with Ionis Pharmaceuticals, announcing Monday that the medicine, dubbed BIIB078, ...

Article found on: www.biopharmadive.com

View Original Article